1015 related articles for article (PubMed ID: 31770441)
21. Evidence-based management of immune thrombocytopenia: ASH guideline update.
Neunert CE; Cooper N
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):568-575. PubMed ID: 30504359
[TBL] [Abstract][Full Text] [Related]
22. Management of immune thrombocytopenic purpura in adults.
Stasi R; Provan D
Mayo Clin Proc; 2004 Apr; 79(4):504-22. PubMed ID: 15065616
[TBL] [Abstract][Full Text] [Related]
23. Clinical decisions in idiopathic thrombocytopenic purpura.
George JN; Raskob GE
Hosp Pract (1995); 1997 Sep; 32(9):159-60, 163-6, 169-70, passim. PubMed ID: 9307602
[TBL] [Abstract][Full Text] [Related]
24. Immune thrombocytopenia.
Kistangari G; McCrae KR
Hematol Oncol Clin North Am; 2013 Jun; 27(3):495-520. PubMed ID: 23714309
[TBL] [Abstract][Full Text] [Related]
25. An update on pediatric ITP: differentiating primary ITP, IPD, and PID.
Grace RF; Lambert MP
Blood; 2022 Aug; 140(6):542-555. PubMed ID: 34479363
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic approaches to secondary immune thrombocytopenic purpura.
Bussel JB
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S44-58. PubMed ID: 19245934
[TBL] [Abstract][Full Text] [Related]
27. Immune thrombocytopenic purpura.
Psaila B; Bussel JB
Hematol Oncol Clin North Am; 2007 Aug; 21(4):743-59, vii. PubMed ID: 17666288
[TBL] [Abstract][Full Text] [Related]
28. Management of children with acute and chronic immune thrombocytopenic purpura.
Kühne T; Imbach P
Transfus Sci; 1998 Sep; 19(3):261-8. PubMed ID: 10351138
[TBL] [Abstract][Full Text] [Related]
29. Chronic idiopathic thrombocytopenic purpura: present strategy, guidelines and new insights.
Stevens W; Koene H; Zwaginga JJ; Vreugdenhil G
Neth J Med; 2006 Nov; 64(10):356-63. PubMed ID: 17122451
[TBL] [Abstract][Full Text] [Related]
30. Primary and secondary immune thrombocytopenia (ITP): Time for a rethink.
González-López TJ; Provan D; Bárez A; Bernardo-Gutiérrez A; Bernat S; Martínez-Carballeira D; Jarque-Ramos I; Soto I; Jiménez-Bárcenas R; Fernández-Fuertes F
Blood Rev; 2023 Sep; 61():101112. PubMed ID: 37414719
[TBL] [Abstract][Full Text] [Related]
31. [Controversies in the treatment of paediatric immune thrombocytopenia].
Berrueco R; Dapena JL; Sebastián E; Sastre A
An Pediatr (Engl Ed); 2018 Sep; 89(3):189.e1-189.e8. PubMed ID: 30033108
[TBL] [Abstract][Full Text] [Related]
32. Immune thrombocytopenia.
Bussel J; Cooper N; Boccia R; Zaja F; Newland A
Expert Rev Hematol; 2021 Nov; 14(11):1013-1025. PubMed ID: 34720027
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
[TBL] [Abstract][Full Text] [Related]
34. Advances in the management of ITP in children and adults.
Imbach P
Clin Adv Hematol Oncol; 2014 Jun; 12(6):384-7. PubMed ID: 25003568
[No Abstract] [Full Text] [Related]
35. Immune thrombocytopenia in adults: A single-centre review of demographics, clinical features and treatment outcomes.
Woolley P; Newton R; Mc Guckin S; Thomas M; Westwood JP; Scully MA
Eur J Haematol; 2020 Sep; 105(3):344-351. PubMed ID: 32474953
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update.
Yang R; Han ZC
Int J Hematol; 2000 Jan; 71(1):18-24. PubMed ID: 10729989
[TBL] [Abstract][Full Text] [Related]
37. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
Rodeghiero F; Stasi R; Gernsheimer T; Michel M; Provan D; Arnold DM; Bussel JB; Cines DB; Chong BH; Cooper N; Godeau B; Lechner K; Mazzucconi MG; McMillan R; Sanz MA; Imbach P; Blanchette V; Kühne T; Ruggeri M; George JN
Blood; 2009 Mar; 113(11):2386-93. PubMed ID: 19005182
[TBL] [Abstract][Full Text] [Related]
38. Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults.
George JN
Curr Hematol Rep; 2003 Sep; 2(5):381-7. PubMed ID: 12932309
[TBL] [Abstract][Full Text] [Related]
39. Immune thrombocytopenic purpura: historical perspective, current status, recent advances and future directions.
Anoop P
Indian Pediatr; 2012 Oct; 49(10):811-8. PubMed ID: 23144100
[TBL] [Abstract][Full Text] [Related]
40. Immune thrombocytopenic purpura: a presentation of HIV infection.
Shah I
J Int Assoc Provid AIDS Care; 2013; 12(2):95-7. PubMed ID: 23087202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
